Ministers gathering in Luxembourg on Friday (21 June) for the final Health Council of the Belgian European Council Presidency will grapple with one of the thorniest issues of the pharmaceutical package, that of incentives.
Striking a balance between incentivising innovation and improving access to medicines has been one of the central issues in the debate on the future pharma package with stakeholders having a significant divergence in…
